You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis Virus

Showing 1 - 25 of 9,852
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Seroconversion of Hepatitis c Virus Among CKD on Regular

Not yet recruiting
  • Hepatitis C Virus
    • (no location specified)
    Oct 25, 2023

    Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

    Not yet recruiting
    • Chronic Hepatitis Delta Virus Infection
    • HH-003(20mg/kg)
    • +2 more
    • (no location specified)
    May 7, 2023

    Interaction Between Hepatitis C Virus Infection and Pregnancy

    Enrolling by invitation
    • Hepacivirus
    • Pregnancy
    • HCV infection status
    • Beijing, China
      Beijing Ditan Hospital
    Jun 24, 2023

    Exposure to Hepatitis E Virus in Occitania, France

    Not yet recruiting
    • Hepatitis E
    • questionnaire
    • (no location specified)
    Nov 13, 2023

    Hepatitis B Virus Reactivation:Cautionary Event After Liver

    Completed
    • Liver Transplant; Complications
    • Diagnosis of postoperative recurrence of liver cancer
    • (no location specified)
    Oct 27, 2023

    Occult Hepatitis C Virus Infection in Patients Born Before 1969

    Not yet recruiting
    • Hepatitis C, Chronic
    • +2 more
    • Meridan Bioscience Point of Care test against HCV antibodies
    • (no location specified)
    Apr 2, 2023

    Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

    Not yet recruiting
    • Cutaneous Warts
    • Hepatitis B Virus Vaccine(HBV)
    • (no location specified)
    Jun 13, 2023

    Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)

    Not yet recruiting
    • Chronic Hepatitis b
    • Rotterdam, Netherlands
      Erasmus MC
    Apr 21, 2023

    Burden of Hepatitis D Virus Infection in China Through

    Not yet recruiting
    • Hepatitis D
    • +3 more
    • HDV-Ab (IgG), HDV-RNA, RNA genotype
    • (no location specified)
    Nov 1, 2022

    Hepatitis C Virus Infection

    Active, not recruiting
    • Hepatitis C
    • Hepatitis B
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 30, 2022

      IBD Trial (standard hepatitis B vaccine, accelerated HBV Vaccine)

      Not yet recruiting
      • Inflammatory Bowel Diseases
      • standard hepatitis B vaccine
      • accelerated HBV Vaccine
      • (no location specified)
      Jul 27, 2023

      Hepatic Steatosis and Chronic Hepatitis B Virus

      Not yet recruiting
      • Chronic Hepatitis
      • Liver biopsy
      • Sohag, Egypt
        Faculty of medicine
      Dec 28, 2022

      Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

      Terminated
      • Hepatitis B, Chronic
      • Hepatitis D
      • Chisinau, Republic Of Moldova, Moldova, Republic of
      • +1 more
      Nov 15, 2022

      Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

      Not yet recruiting
      • Chronic Hepatitis B
      • (no location specified)
      Feb 28, 2023

      Gut Microbiome in People Living With HIV and HBV

      Not yet recruiting
      • Human Immunodeficiency Virus
      • +2 more
        • (no location specified)
        Nov 8, 2023

        Hepatitis c and Linkage to Treatment in Hospitals in Colombia

        Not yet recruiting
        • Hepatitis C Virus Infection
        • rapid diagnostic test HCV Ab Plus Rapid test
        • Medellín, Antioquia, Colombia
          Hospital Pablo Tobón Uribe
        Nov 24, 2023

        Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
        • (no location specified)
        Jun 12, 2023

        Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

        Not yet recruiting
        • Chronic Hepatitis b
        • +2 more
        • Anti-PD-1 antibody
        • +2 more
        • Chongqing, Chongqing, China
          The 2nd affiliated Hospital of Chongqing Medical University
        Mar 14, 2023

        Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

        Not yet recruiting
        • Chronic Hepatitis b
        • Anti-PD-1 Antibody
        • Anti-PD-1 antibody
        • NAs
        • Chongqing, Chongqing, China
          The 2nd affiliated Hospital of Chongqing Medical University
        Mar 3, 2023

        Protect Egyptian Population Against Severe Corona Virus

        Completed
        • Corona Virus Infection
        • Hepatitis
          • Zagazig, Sharkia, Egypt
            Zagazig University Hospitals
          Sep 28, 2022

          Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent Trial in New York, Hong Kong, Singapore

          Recruiting
          • Hepatitis B Virus Related Hepatocellular Carcinoma
          • Hepatocellular Carcinoma Recurrent
          • SCG101
          • New York, New York
          • +4 more
          Nov 18, 2022

          Cell-free DNA From Junction of Hepatitis B Virus Integration in

          Active, not recruiting
          • Hepatocellular Carcinoma
            • Taipei, Taiwan
              National Taiwan University Hospital
            Apr 10, 2023

            Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

            Recruiting
            • Lung Transplant
            • Hepatitis B
            • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
            • Philadelphia, Pennsylvania
              Hospital of University of Pennsylvania
            Oct 1, 2022

            Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

            Not yet recruiting
            • Liver Cancer
            • Houston, Texas
              M D Anderson Cancer Center
            Feb 9, 2023

            Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)

            Completed
            Has Results
            • Hepatitis D, Chronic
            • Peginterferon Lambda-1A
            • Beersheba, Israel
            • +3 more
            Dec 20, 2022